Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals ($VRTX), made one open market sale of company shares in the last year, totaling $1.12 million. Her most recent sale occurred on February 27, 2026. This places her 4,669th out of 11,678 insiders by sale value, well below the average of $8.6 million across 6.37 transactions per insider. She reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 27, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | S | Common Stock | 2329 | $450.95 | 33,076.0000 | 258,000,000 | 6.58% | 0.00% |
| March 13, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | S | Common Stock | 2329 | $481.79 | 35,405.0000 | 258,000,000 | 6.17% | 0.00% |
| Feb. 27, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | S | Common Stock | 2329 | $480.31 | 37,734.0000 | 258,000,000 | 5.81% | 0.00% |
| Feb. 24, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | F | Common Stock | 1453 | $485.11 | 40,063.0000 | 258,000,000 | 3.50% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | F | Common Stock | 1912 | $483.75 | 41,516.0000 | 258,000,000 | 4.40% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | A | Common Stock | 5375 | $0.00 | 43,428.0000 | 258,000,000 | 14.13% | 0.00% |
| Feb. 13, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | F | Common Stock | 3804 | $487.76 | 38,053.0000 | 258,000,000 | 9.09% | 0.00% |
| Feb. 10, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | F | Common Stock | 2145 | $468.41 | 41,857.0000 | 258,000,000 | 4.87% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | A | Common Stock | 3467 | $0.00 | 44,002.0000 | 258,000,000 | 8.55% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | A | Common Stock | 7866 | $0.00 | 40,535.0000 | 258,000,000 | 24.08% | 0.00% |
| Feb. 26, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | F | Common Stock | 4962 | $479.61 | 32,669.0000 | 257,899,999 | 13.19% | 0.00% |
| Feb. 24, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | F | Common Stock | 3310 | $483.28 | 37,631.0000 | 257,899,999 | 8.08% | 0.00% |
| Feb. 14, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | F | Common Stock | 1912 | $463.46 | 40,941.0000 | 257,899,999 | 4.46% | 0.00% |
| Feb. 12, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | A | Common Stock | 5546 | $0.00 | 42,853.0000 | 257,899,999 | 14.87% | 0.00% |
| Feb. 10, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | F | Common Stock | 2142 | $467.98 | 37,307.0000 | 257,899,999 | 5.43% | 0.00% |
| Feb. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | A | Common Stock | 10262 | $0.00 | 33,521.0000 | 257,899,999 | 44.12% | 0.00% |
| Feb. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | A | Common Stock | 5928 | $0.00 | 39,449.0000 | 257,899,999 | 17.68% | 0.00% |
| Aug. 7, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | S | Common Stock | 2280 | $476.75 | 23,259.0000 | 260,500,000 | 8.93% | 0.00% |
| July 24, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | S | Common Stock | 2280 | $488.46 | 25,539.0000 | 260,500,000 | 8.20% | 0.00% |
| July 10, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | S | Common Stock | 2280 | $487.34 | 27,819.0000 | 260,500,000 | 7.58% | 0.00% |
| June 26, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | S | Common Stock | 2280 | $471.72 | 30,099.0000 | 260,500,000 | 7.04% | 0.00% |
| June 12, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | S | Common Stock | 2280 | $478.00 | 32,379.0000 | 260,500,000 | 6.58% | 0.00% |
| May 29, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | S | Common Stock | 2280 | $445.56 | 34,659.0000 | 260,500,000 | 6.17% | 0.00% |
| Feb. 23, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | F | Common Stock | 3309 | $431.79 | 36,939.0000 | 260,500,000 | 8.22% | 0.00% |
| Feb. 20, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | F | Common Stock | 2812 | $420.58 | 40,248.0000 | 260,500,000 | 6.53% | 0.00% |
| Feb. 16, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | F | Common Stock | 3750 | $424.01 | 43,060.0000 | 260,500,000 | 8.01% | 0.00% |
| Feb. 9, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | F | Common Stock | 2100 | $422.74 | 46,810.0000 | 260,500,000 | 4.29% | 0.00% |
| Feb. 6, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | A | Common Stock | 7866 | $0.00 | 42,982.0000 | 260,500,000 | 22.40% | 0.00% |
| Feb. 7, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | A | Common Stock | 5928 | $0.00 | 48,910.0000 | 260,500,000 | 13.79% | 0.00% |
| Feb. 6, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Bozic Carmen | EVP and CMO | A | Common Stock | 5814 | $0.00 | 35,116.0000 | 260,500,000 | 19.84% | 0.00% |